10 June 2025
EU Member States vote in favour of the first-ever IPI measures
1 min read
The EU is set to make the first use of its enforcement powers under the International Procurement Instrument.
The EU is set to make the first use of its enforcement powers under the International Procurement Instrument (IPI) and, after failing to persuade the Chinese government to open Chinese markets to EU producers, intends to severely curtail access of Chinese medical device makers to the EU. This will be a test case for the IPI, and it remains to be seen whether its use, alone or in conjunction with other instruments in the EU’s toolbox, will improve market access and lead to a more open EU-China trade relationship.
Our client alert below explores more.
Attachments:
Key contacts
News & insights
5 min
read
read
Briefings
EU and Mexico Launch High-Level Dialogue on Health: Implications for Life Sciences Companies
5 November 2026
Brussels / Mexico City, 5 November 2026 — Joint client alert by Van Bael & Bellis and Arochi & Lindner
10 min
read
read
Briefings
The EU catch-all clause: why unlisted dual-use goods may still require an export licence
30 October 2026
10 min
read
read
Briefings
Dual-Use Items: AG Backs Broad Test in Case C-538/25
13 October 2026
10 min
read
read
Briefings
China arms embargo: political pledge, real compliance risks
18 November 2026
1 min
read
read
Briefings
EU General Court Ruling on Customs Classification of Split Consignments in EU Assembly Operations
9 October 2026
2 min
read
read
Briefings
Poland – Polish Competition Authority Fines Medicine Wholesalers for Illegally Exchanging Confidential Information
23 September 2026
2 min
read
read
Briefings
Belgian Competition Authority Imposes fine of EUR 29.8 Million on Pharmaceutical Wholesaler Pharma Belgium-Belmedis
18 February 2022
2 min
read
read
Briefings
Belgium Publishes Third Annual Report Regarding Screening of Foreign Direct Investment
11 September 2026